Pamela Silver
Home » Health and medicine » COVID-19 » SynBioBeta Live: the State of the industry with Pamela Silver

SynBioBeta Live: the State of the industry with Pamela Silver

Wednesday, April 22, 2020, 8 am PDT

Pamela is a founding member of the Department of Systems Biology at Harvard Medical School. Her work involves building synthetic cells that act as sensors, memory devices, bio-computers, producers of high-value commodities and energy from the sun, and novel subsystems such as proteins with designed properties for therapeutic use. Among her most recent innovations are bacteria that can sense and respond to gut inflammation. She also created the Bionic Leaf, which couples sunlight capture to bioproduction at an efficiency exceeding plants.

Pamela will share her thoughts on:

  • What our response to the novel coronavirus reveals to her about science and technology
  • What synthetic biology is doing well, and what work remains to be done
  • How Pamela see the future of health, medicine, and industry



Kevin Costa

As Editor and Program Manager, Kevin leads SynBioBeta's digital media content, with the goal of telling the story of the people, companies, and ideas shaping the future with biology. Before joining SynBioBeta, Kevin managed the Synthetic Biology Engineering Research Center. His interests include public engagement, science writing, community building, and bikes!

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to

Add comment

Job opportunities